QQ客服 官方微博 反馈留言

	Peripheral CB1 Receptor Neutral Antagonist, AM6545, Ameliorates Hypometabolic Obesity and Improves Adipokine Secretion in Monosodium Glutamate Induced Obese Mice
	Fu, Xiujuan; Ma, Haiming; Zhang, Guina; Mou, Chunrong; Chen, Yadan
刊名	FRONTIERS IN PHARMACOLOGY
	2018
卷号	9
关键词	CB1 receptor AM6545 peripheral obesity antagonist
ISSN号	1663-9812
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3513738
专题	吉林大学白求恩第三医院
推荐引用方式 GB/T 7714	Fu, Xiujuan,Ma, Haiming,Zhang, Guina,et al. Peripheral CB1 Receptor Neutral Antagonist, AM6545, Ameliorates Hypometabolic Obesity and Improves Adipokine Secretion in Monosodium Glutamate Induced Obese Mice[J]. FRONTIERS IN PHARMACOLOGY,2018,9.
APA	Fu, Xiujuan,Ma, Haiming,Zhang, Guina,Mou, Chunrong,&Chen, Yadan.(2018).Peripheral CB1 Receptor Neutral Antagonist, AM6545, Ameliorates Hypometabolic Obesity and Improves Adipokine Secretion in Monosodium Glutamate Induced Obese Mice.FRONTIERS IN PHARMACOLOGY,9.
MLA	Fu, Xiujuan,et al."Peripheral CB1 Receptor Neutral Antagonist, AM6545, Ameliorates Hypometabolic Obesity and Improves Adipokine Secretion in Monosodium Glutamate Induced Obese Mice".FRONTIERS IN PHARMACOLOGY 9(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。